Francesca Galli

1.6k total citations
57 papers, 551 citations indexed

About

Francesca Galli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Francesca Galli has authored 57 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Francesca Galli's work include COVID-19 and healthcare impacts (6 papers), Pain Management and Opioid Use (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Francesca Galli is often cited by papers focused on COVID-19 and healthcare impacts (6 papers), Pain Management and Opioid Use (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Francesca Galli collaborates with scholars based in Italy, United States and Switzerland. Francesca Galli's co-authors include Irene Floriani, Roberto Ratiglia, Eliana Rulli, Nicole Corsi, Elena Biagioli, Oscar Corli, Nicoletta Colombo, Lorenzo Ceppi, Robert Fruscio and Cristina Bonazzi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Francesca Galli

48 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Galli Italy 14 170 125 81 77 76 57 551
Esma A. Akin United States 13 79 0.5× 96 0.8× 107 1.3× 41 0.5× 76 1.0× 40 601
Yoshiaki Ota United States 15 105 0.6× 77 0.6× 119 1.5× 75 1.0× 78 1.0× 70 710
Klaus Pietzner Germany 17 222 1.3× 248 2.0× 117 1.4× 90 1.2× 127 1.7× 91 782
Shung‐Shung Sun Taiwan 13 110 0.6× 66 0.5× 74 0.9× 69 0.9× 135 1.8× 62 539
Marialuisa Framarino‐dei‐Malatesta Italy 17 117 0.7× 95 0.8× 220 2.7× 103 1.3× 94 1.2× 54 735
Jergin Chen United States 10 241 1.4× 51 0.4× 100 1.2× 253 3.3× 100 1.3× 15 806
Young Kwon Hong South Korea 14 122 0.7× 44 0.4× 123 1.5× 44 0.6× 240 3.2× 43 687
Andrea Burgetová Czechia 16 69 0.4× 255 2.0× 251 3.1× 94 1.2× 92 1.2× 75 740
Yves Van Belle Belgium 20 55 0.3× 243 1.9× 364 4.5× 49 0.6× 40 0.5× 41 1.4k
Daigo Ochiai Japan 14 42 0.2× 42 0.3× 228 2.8× 82 1.1× 88 1.2× 58 576

Countries citing papers authored by Francesca Galli

Since Specialization
Citations

This map shows the geographic impact of Francesca Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Galli more than expected).

Fields of papers citing papers by Francesca Galli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Galli. The network helps show where Francesca Galli may publish in the future.

Co-authorship network of co-authors of Francesca Galli

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Galli. A scholar is included among the top collaborators of Francesca Galli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Galli. Francesca Galli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Proto, Claudia, Arsela Prelaj, Laura Mazzeo, et al.. (2025). 40P: Metformin plus/minus cyclic fasting mimicking diet to improve the efficacy of first-line chemo-immunotherapy in advanced LKB1-inactive NSCLC: Results of the phase II trial FAME. Journal of Thoracic Oncology. 20(3). S36–S37. 1 indexed citations
2.
Proto, Claudia, Giuseppe Lo Russo, Arsela Prelaj, et al.. (2025). Tracking the Response to Immunotherapy: Blood microRNA Dynamics in Patients With Advanced Non–Small Cell Lung Cancer. JCO Precision Oncology. 9(9). e2400790–e2400790. 1 indexed citations
3.
4.
5.
Mandalà, Mario, Piotr Rutkowski, Francesca Galli, et al.. (2022). Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study. ESMO Open. 7(3). 100469–100469. 4 indexed citations
6.
Galli, Francesca & Luigi Mariani. (2022). Two-stage re-estimation adaptive design: a simulation study. SHILAP Revista de lepidopterología. 11(1).
7.
Christou, Niki, Elisabeth Bergen, Karine Le Malicot, et al.. (2022). Impact of diabetes and metformin use on recurrence and outcome in stage II–III colon cancer patients—A pooled analysis of three adjuvant trials. European Journal of Cancer. 166. 100–111. 11 indexed citations
8.
Angeli, Enzo, Stefano Marchese, Francesca Galli, et al.. (2021). Prognostic value of CT integrated with clinical and laboratory data during the first peak of the COVID-19 pandemic in Northern Italy: A nomogram to predict unfavorable outcome. European Journal of Radiology. 137. 109612–109612. 15 indexed citations
9.
Rosati, Gerardo, Francesca Galli, Sara Lonardi, et al.. (2020). 399O Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in elderly patients: A subgroup analysis from TOSCA trial. Annals of Oncology. 31. S410–S411. 1 indexed citations
10.
Reni, Michele, Silvia Zanon, Gianpaolo Balzano, et al.. (2017). Randomized phase 2 trial of peri- or post-operative chemotherapy in resectable pancreatic adenocarcinoma. Annals of Oncology. 28. vi44–vi44. 1 indexed citations
11.
12.
Quaranta, Luciano, Elena Biagioli, Ivano Riva, et al.. (2017). The Glaucoma Italian Pediatric Study (GIPSy): 1-Year Results. Journal of Glaucoma. 26(11). 987–994. 3 indexed citations
13.
Quaranta, Luciano, Elena Biagioli, Francesca Galli, et al.. (2016). Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics. Advances in Therapy. 33(8). 1305–1315. 5 indexed citations
14.
Graziano, Francesco, Annamaria Ruzzo, Eliana Rulli, et al.. (2016). Dihydropyrimidine dehydrogenase (DPYD) gene polymorphisms profiling in colon cancer patients treated with adjuvant chemotherapy in the randomized phase III TOSCA trial. Annals of Oncology. 27. iv1–iv1. 1 indexed citations
15.
Personeni, Nicola, Lorenza Rimassa, Claudio Verusio, et al.. (2015). FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study. Clinical Colorectal Cancer. 14(3). 162–169. 9 indexed citations
16.
Luciani, Andrea, Laura Biganzoli, Giuseppe Colloca, et al.. (2015). Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13). Journal of Geriatric Oncology. 6(4). 272–279. 62 indexed citations
17.
Fabbro, Massimo Del, Tiziano Testori, Francesca Galli, et al.. (2010). The Therapeutic Approach of the Galeazzi Orthopaedic Institute Implant Department. 189–285. 1 indexed citations
18.
Zuffetti, Francesco, Francesca Bianchi, Paolo Trisi, et al.. (2009). Clinical application of bisphosphonates in implant dentistry: histomorphometric evaluation.. PubMed. 29(1). 31–9. 17 indexed citations
19.
Zuffetti, Francesco, Francesca Galli, Silvio Taschieri, et al.. (2007). SCHEDA OPERATIVA - La tecnica chirurgica step by step: Seconda fase chirurgica con innesto connettivale. 6(5). 31–33.
20.
Gagliardo, Andrea, Francesca Galli, Antonello Grippo, et al.. (2007). Motor evoked potentials in multiple sclerosis patients without walking limitation: amplitude vs. conduction time abnormalities. Journal of Neurology. 254(2). 220–227. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esma A. Akin Breakdown of academic impact, for papers by Yoshiaki Ota Breakdown of academic impact, for papers by Klaus Pietzner Breakdown of academic impact, for papers by Shung‐Shung Sun Breakdown of academic impact, for papers by Marialuisa Framarino‐dei‐Malatesta Breakdown of academic impact, for papers by Jergin Chen Breakdown of academic impact, for papers by Young Kwon Hong Breakdown of academic impact, for papers by Andrea Burgetová Breakdown of academic impact, for papers by Yves Van Belle Breakdown of academic impact, for papers by Daigo Ochiai
Rankless by CCL
2026